At a glance
- Originator Boehringer Ingelheim Pharma KG
- Class Antihyperglycaemics; Benzoic acids
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Type 2 diabetes mellitus
Most Recent Events
- 12 Dec 1994 Discontinued-Unspecifed Phase in Arrhythmias in Germany (Transdermal)
- 12 Dec 1994 Investigation in Type-2 diabetes mellitus in Germany (Unknown route)